GERALD SPROUT: Open Payments
NPI 1861916363 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,681 in 214 payments from 20 companies in 2025. Trend: 2023 $628 · 2024 $975 · 2025 $3,681
Food & beverage: $3,604Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 46 | $647 |
| Janssen Biotech, Inc. | 38 | $483 |
| Takeda Pharmaceuticals U.S.A., Inc. | 20 | $378 |
| GENZYME CORPORATION | 9 | $324 |
| Madrigal Pharmaceuticals | 11 | $247 |
| Ardelyx, Inc. | 12 | $228 |
| Regeneron Healthcare Solutions, Inc. | 7 | $198 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $196 |
| Aimmune Therapeutics, Inc. | 23 | $192 |
| Ipsen Biopharmaceuticals, Inc | 7 | $160 |
Products named: DUPIXENT, TREMFYA, RINVOQ, ENTYVIO, REZDIFFRA, IBSRELA, XIFAXAN, Sucraid.
Industry payments across SC — which companies pay providers there.
